Fionna Kossmann, Sr. Global Claims Manager - Life & Health, Gen Re and Dr. Jonah Fox, Chief Medical Officer Global Claims, Gen Re
This presentation explores the changing world of work and how it is challenging us to rethink our insurance products and processes. We introduce the concept of an innovative abilities-based product idea and take you on a journey of how this might be implemented throughout the insurance value chain. We also cover some of the potential impacts of automation on mortality trends. It's an exciting and informative hour that will challenge your thinking and inspire you to embrace the future of work!
Dewesh Kumar, Head of Analytics, Gen Re and Nathan Mecray, Actuary, Gen Re
This session explores some statistical techniques that enable a multivariate approach for insurance pricing. Viewers will gain insights into how these methods can help reshape traditional pricing methods and facilitate a shift from single variable experience analysis to more rigorous data-driven models capturing multidimensional relationships.
Key takeaways from the session areas follows:
Dr. John O'Brien, Segment Chief Medical Officer
This webinar discusses different approaches to potentially slowing the ageing process, such as the pharmacological drug rapamycin, telomere length in DNA, or metabolism regulation by sirtuin enzymes – to name a few. Could we have more control over our ageing than we think? There are many promising targets for modulation of the ageing process.
Beata Puls, Senior Actuary, Gen Re
Beata provided an overview of mortality and mortality improvement rates in the USA. She identified patterns in historical mortality trends and causes of death driving these patterns. The decomposition of mortality trends by causes of death benefits the understanding of past mortality trends and aids the practitioner in projecting mortality improvement rates. Beata also discussed a range of risk factors such as socioeconomic status that drive changes in mortality. Despite the direct impact of COVID-19 as well as the recent slowdown in mortality improvements rates across multiple countries there is continued improvement in most ages. When writing long-term guaranteed business the future impact on mortality needs to be assessed carefully considering causes of death and risk factors that drive changes in mortality.
by Eva Odenkirchen and Nicolas Zimmer
COVID-19 has now been with us for two years. It has hit the global life insurance industry hard. Although we can’t predict the ultimate course of pandemic, we expect the virus to impact global mortality in the near future.
by Beata Puls and Valeria Walter
Managing mortality risks is at the core of the Life insurance business. Here are results of our analysis focusing on population mortality in Germany.
by David Hatherell and Tanya van Niekerk
The effects of the COVID‑19 pandemic have been discussed widely and in depth, with lockdown measures and restrictions on travel and trading having a severe impact on the global economy.